| 1 | Disseminated Intravascular Coagulation | 37% |
| 2 | Protein S Deficiency | 37% |
| 3 | Thrombocythemia, Essential | 36.1% |
| 4 | Thrombasthenia | 28.8% |
| 5 | Antithrombin III Deficiency | 28.8% |
| 6 | Protein C Deficiency | 28.8% |
| 7 | Abdominal Neoplasms | 28.6% |
| 8 | Anemia | 28.6% |
| 9 | Blood Coagulation Disorders | 28.6% |
| 10 | Blood Platelet Disorders | 28.6% |
| 11 | Bone Marrow Diseases | 28.6% |
| 12 | Head and Neck Neoplasms | 28.6% |
| 13 | Hemorrhagic Disorders | 28.6% |
| 14 | Leukocyte Disorders | 28.6% |
| 15 | Methemoglobinemia | 28.6% |
| 16 | Pancytopenia | 28.6% |
| 17 | Polycythemia | 28.6% |
| 18 | Soft Tissue Neoplasms | 28.6% |
| 19 | Sulfhemoglobinemia | 28.6% |
| 20 | Thoracic Neoplasms | 28.6% |
| 21 | Thrombophilia | 28.6% |
| 22 | Erythrocytosis | 28.6% |
| 23 | Thrombocytosis | 28.2% |
| 24 | Afibrinogenemia | 27% |
| 25 | Factor VII Deficiency | 27% |
| 26 | Factor X Deficiency | 27% |
| 27 | Factor XII Deficiency | 27% |
| 28 | Hemophilia A | 27% |
| 29 | Activated Protein C Resistance | 27% |
| 30 | Factor II deficiency | 27% |
| 31 | Factor VIII Deficiency | 27% |
| 32 | Factor V deficiency | 27% |
| 33 | Factor XI Deficiency | 27% |
| 34 | Hypoprothrombinemias | 27% |
| 35 | Splenic Neoplasms | 26.3% |
| 36 | Hemoglobinuria, Paroxysmal | 25.4% |
| 37 | Leukemoid Reaction | 25.4% |
| 38 | Vitamin K Deficiency | 24.4% |
| 39 | Anemia, Diamond-Blackfan | 23.3% |
| 40 | Thymus Neoplasms | 22.8% |
| 41 | Digestive System Neoplasms | 22.2% |
| 42 | Endocrine Gland Neoplasms | 22.2% |
| 43 | Eye Neoplasms | 22.2% |
| 44 | Nervous System Neoplasms | 22.2% |
| 45 | Transfusion Reaction | 22.2% |
| 46 | Hypotensive Transfusion Reaction | 22.2% |
| 47 | Bone neoplasms | 21.4% |
| 48 | Pregnancy Complications, Hematologic | 21.4% |
| 49 | Skin Neoplasms | 21.4% |
| 50 | Anemia, Hemolytic | 20.9% |
| 51 | Anemia, Macrocytic | 20.9% |
| 52 | Eosinophilia | 20.9% |
| 53 | Hypoproteinemia | 20.9% |
| 54 | Leukopenia | 20.9% |
| 55 | Parathyroid Neoplasms | 20.9% |
| 56 | Peritoneal Neoplasms | 20.9% |
| 57 | Retroperitoneal Neoplasms | 20.9% |
| 58 | Thrombocytopenia | 20.9% |
| 59 | Thyroid Neoplasm | 20.9% |
| 60 | Leukostasis | 20.9% |
| 61 | Thyroid carcinoma | 20.9% |
| 62 | MYELODYSPLASTIC SYNDROME | 20.9% |
| 63 | Purpura, Thrombotic Thrombocytopenic | 20.8% |
| 64 | Acanthoma | 19.7% |
| 65 | Wiskott-Aldrich Syndrome | 19.5% |
| 66 | Tracheal Neoplasms | 19.1% |
| 67 | Thymoma | 18.4% |
| 68 | Paraneoplastic Encephalomyelitis | 18.3% |
| 69 | Pancreatic Neoplasm | 18% |
| 70 | Mammary Neoplasms, Experimental | 17.9% |
| 71 | Anemia, Sickle Cell | 17.7% |
| 72 | Thalassemia | 17.7% |
| 73 | Waldenstrom Macroglobulinemia | 17.6% |
| 74 | Primary Myelofibrosis | 17.2% |
| 75 | Agranulocytosis | 17.2% |
| 76 | Anemia, Megaloblastic | 17.2% |
| 77 | Lymphocytosis | 17.2% |
| 78 | Myelofibrosis | 17.2% |
| 79 | Myeloid Metaplasia | 17.2% |
| 80 | Hypoalbuminemia | 17.2% |
| 81 | Hypereosinophilic syndrome | 17.2% |
| 82 | bone marrow fibrosis | 17.2% |
| 83 | Thrombotic Microangiopathies | 17.2% |
| 84 | Multiple Endocrine Neoplasia | 17% |
| 85 | Leukemia, Myelomonocytic, Chronic | 16.9% |
| 86 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 16.9% |
| 87 | Cryoglobulinemia | 16.9% |
| 88 | Monoclonal Gammopathy of Undetermined Significance | 16.9% |
| 89 | Thyroid Nodule | 16.9% |
| 90 | Agammaglobulinemia | 16.7% |
| 91 | Polycythemia Vera | 16.7% |
| 92 | Autoimmune thrombocytopenia | 16.5% |
| 93 | Immune thrombocytopenic purpura | 16.5% |
| 94 | Esophageal Neoplasms | 15.9% |
| 95 | Anemia, Neonatal | 15.8% |
| 96 | Leukocytosis | 15.8% |
| 97 | Mouth Neoplasms | 15.8% |
| 98 | Paraproteinemias | 15.8% |
| 99 | Pelger-Huet Anomaly | 15.8% |
| 100 | Central Nervous System Neoplasms | 15.8% |
| 101 | Pleocytosis | 15.8% |
| 102 | Vascular Neoplasms | 15.8% |
| 103 | Hemolytic-Uremic Syndrome | 15.7% |
| 104 | Genital Neoplasms, Female | 15.5% |
| 105 | Neutropenia | 15.4% |
| 106 | Breast Neoplasms, Male | 15.4% |
| 107 | Triple Negative Breast Neoplasms | 15.4% |
| 108 | Sickle Cell Trait | 15.4% |
| 109 | Carcinoma, Lobular | 15.3% |
| 110 | Leukemia, Myeloid, Chronic-Phase | 15.1% |
| 111 | Multiple Myeloma | 15.1% |
| 112 | Fanconi Anemia | 15.1% |
| 113 | Hamartoma | 15% |
| 114 | Lymphatic Diseases | 15% |
| 115 | Neoplasms, Hormone-Dependent | 15% |
| 116 | Neoplasms, Multiple Primary | 15% |
| 117 | Paraneoplastic Syndromes | 15% |
| 118 | Precancerous Conditions | 15% |
| 119 | Neoplasms, Second Primary | 15% |
| 120 | Febrile Neutropenia | 14.5% |
| 121 | Atypical Hemolytic Uremic Syndrome | 14.4% |
| 122 | Heavy Chain Disease | 14.3% |
| 123 | Lymphocele | 14.3% |
| 124 | Meningioma | 14.3% |
| 125 | Purpura, Hyperglobulinemic | 14.3% |
| 126 | Carcinoma, Pancreatic Ductal | 14.3% |
| 127 | Testicular Neoplasms | 14% |
| 128 | Thrombocytopenic purpura | 13.9% |
| 129 | Infectious Mononucleosis | 13.6% |
| 130 | Hemangioma, Cavernous | 13.5% |
| 131 | Lymphopenia | 13% |
| 132 | Multiple Endocrine Neoplasia Type 1 | 13% |
| 133 | insulinoma | 12.9% |
| 134 | Vipoma | 12.9% |
| 135 | Gastrinoma | 12.8% |
| 136 | Glucagonoma | 12.8% |
| 137 | Meningeal Neoplasms | 12.8% |
| 138 | Job Syndrome | 12.8% |
| 139 | Adrenal Gland Neoplasms | 12.7% |
| 140 | Gastrointestinal Neoplasms | 12.7% |
| 141 | Genital Neoplasms, Male | 12.7% |
| 142 | Hypergammaglobulinemia | 12.7% |
| 143 | Liver neoplasms | 12.7% |
| 144 | Uveal Neoplasms | 12.7% |
| 145 | Urologic Neoplasms | 12.5% |
| 146 | Transfusion-Related Acute Lung Injury | 12.4% |
| 147 | Acoustic Neuroma | 12.4% |
| 148 | Ecchymosis | 12.3% |
| 149 | Petechiae | 12.3% |
| 150 | Purpura | 12.3% |
| 151 | Sebaceous Gland Neoplasms | 12.3% |
| 152 | Spinal Neoplasms | 12.3% |
| 153 | Bone Marrow Neoplasms | 12.3% |
| 154 | Histiocytic Disorders, Malignant | 12.3% |
| 155 | Carcinoma 256, Walker | 11.9% |
| 156 | Palatal Neoplasms | 11.9% |
| 157 | Leukoplakia, Oral | 11.9% |
| 158 | Paraneoplastic Cerebellar Degeneration | 11.8% |
| 159 | Hydrops Fetalis | 11.8% |
| 160 | Acute Chest Syndrome | 11.7% |
| 161 | Pulmonary Eosinophilia | 11.7% |
| 162 | Eosinophilic Pneumonia | 11.7% |
| 163 | Nose Neoplasms | 11.5% |
| 164 | Meningeal Carcinomatosis | 11.4% |
| 165 | Anemia, Pernicious | 11.3% |
| 166 | Carcinoma, Ehrlich Tumor | 11.3% |
| 167 | Dermoid Cyst | 11.3% |
| 168 | Carcinoma, Lewis Lung | 11.3% |
| 169 | Hepatocellular Adenoma | 11.2% |
| 170 | Liver Neoplasms, Experimental | 11.2% |
| 171 | Leydig Cell Tumor | 11.1% |
| 172 | Cyst | 11.1% |
| 173 | Neoplastic Processes | 11.1% |
| 174 | Neoplastic Syndromes, Hereditary | 11.1% |
| 175 | Pregnancy Complications, Neoplastic | 11.1% |
| 176 | Neoplasms, Experimental | 10.9% |
| 177 | Neoplasms, Neuroepithelial | 10.8% |
| 178 | Gliomatosis cerebri | 10.8% |
| 179 | Retinoblastoma | 10.8% |
| 180 | Optic Nerve Glioma | 10.6% |
| 181 | Medulloblastoma | 10.6% |
| 182 | Ear Neoplasms | 10.5% |
| 183 | Eyelid Neoplasms | 10.5% |
| 184 | Lung Neoplasms | 10.5% |
| 185 | Pleural Neoplasms | 10.5% |
| 186 | Eosinophilia-Myalgia Syndrome | 10.3% |
| 187 | Neuroectodermal Tumors | 10.3% |
| 188 | Melanoma, Experimental | 10.3% |
| 189 | Brain Neoplasms | 10.2% |
| 190 | Chronic granulomatous disease | 10.2% |
| 191 | Salivary Gland Neoplasms | 10.2% |
| 192 | Shwartzman Phenomenon | 10.2% |
| 193 | Spinal Cord Neoplasms | 10.2% |
| 194 | Tongue Neoplasms | 10.2% |
| 195 | Pituitary Adenoma | 10.1% |
| 196 | Pituitary Neoplasms | 10.1% |
| 197 | Scurvy | 10.1% |
| 198 | melanoma | 10.1% |
| 199 | Uterine Neoplasms | 10.1% |
| 200 | Vaginal Neoplasms | 10.1% |
| 201 | Vulvar Neoplasms | 10.1% |
| 202 | Purpura Fulminans | 10.1% |
| 203 | Uterine Cancer | 10.1% |
| 204 | Limbic Encephalitis | 10% |
| 205 | Fallopian Tube Neoplasms | 10% |
| 206 | Waterhouse-Friderichsen Syndrome | 9.8% |
| 207 | Lymphoma | 9.7% |
| 208 | Trophoblastic Neoplasms | 9.7% |
| 209 | Eosinophilic Granuloma | 9.7% |
| 210 | Leukemia, Experimental | 9.7% |
| 211 | Composite Lymphoma | 9.6% |
| 212 | Prolactinoma | 9.5% |
| 213 | Growth Hormone-Secreting Pituitary Adenoma | 9.5% |
| 214 | Adenitis | 9.5% |
| 215 | Erythroplasia | 9.5% |
| 216 | Follicular cyst | 9.5% |
| 217 | Histiocytosis | 9.5% |
| 218 | leukemia | 9.5% |
| 219 | Lymphadenitis | 9.5% |
| 220 | Lymphangitis | 9.5% |
| 221 | Lymphedema | 9.5% |
| 222 | Mucocele | 9.5% |
| 223 | Neoplasms, Germ Cell and Embryonal | 9.5% |
| 224 | Neoplasms, Glandular and Epithelial | 9.5% |
| 225 | Pilonidal Cyst | 9.5% |
| 226 | Splenic Diseases | 9.5% |
| 227 | Thymus Hyperplasia | 9.5% |
| 228 | Thyroglossal Cyst | 9.5% |
| 229 | Synovial Cyst | 9.5% |
| 230 | Pseudolymphoma | 9.5% |
| 231 | Lymphadenopathy | 9.5% |
| 232 | Germ Cell Cancer | 9.5% |
| 233 | Aberrant Crypt Foci | 9.5% |
| 234 | Carcinosarcoma | 9.4% |
| 235 | Hemangiosarcoma | 9.4% |
| 236 | Malignant histiocytosis | 9.4% |
| 237 | Leukemia L1210 | 9.4% |
| 238 | Leukemia P388 | 9.4% |
| 239 | lymphangiosarcoma | 9.4% |
| 240 | Histiocytic sarcoma | 9.4% |
| 241 | Lymphomatoid Granulomatosis | 9.4% |
| 242 | Adenoma, Acidophil | 9.3% |
| 243 | Ganglioneuroma | 9.3% |
| 244 | Glioma | 9.3% |
| 245 | Malignant Glioma | 9.3% |
| 246 | Bronchial Neoplasms | 9.3% |
| 247 | Multiple Pulmonary Nodules | 9.2% |
| 248 | Nephroblastoma | 9.2% |
| 249 | Supratentorial Neoplasms | 9% |
| 250 | Carcinoid Tumor | 9% |
| 251 | Endometrial Neoplasms | 9% |
| 252 | Neurilemmoma | 9% |
| 253 | Hutchinson's Melanotic Freckle | 9% |
| 254 | Melanoma, Amelanotic | 9% |
| 255 | Lambert-Eaton Myasthenic Syndrome | 8.9% |
| 256 | Sarcoma 180 | 8.9% |
| 257 | Sarcoma, Experimental | 8.9% |
| 258 | Pharyngeal Neoplasms | 8.8% |
| 259 | ovarian neoplasm | 8.7% |
| 260 | Choriocarcinoma | 8.6% |
| 261 | Neoplasms, Radiation-Induced | 8.6% |
| 262 | Astrocytoma | 8.6% |
| 263 | Ependymoma | 8.6% |
| 264 | oligodendroglioma | 8.6% |
| 265 | Ganglioglioma | 8.6% |
| 266 | gliosarcoma | 8.6% |
| 267 | Anaplastic astrocytoma | 8.6% |
| 268 | Anaplastic Oligodendroglioma | 8.6% |
| 269 | Central Nervous System Cysts | 8.6% |
| 270 | Adrenocortical carcinoma | 8.5% |
| 271 | Bile Duct Neoplasms | 8.5% |
| 272 | Basal cell carcinoma | 8.5% |
| 273 | Carcinoma, Papillary | 8.5% |
| 274 | Squamous cell carcinoma | 8.5% |
| 275 | Chondrosarcoma | 8.5% |
| 276 | Craniopharyngioma | 8.5% |
| 277 | Cystadenoma | 8.5% |
| 278 | gallbladder neoplasm | 8.5% |
| 279 | Intestinal Neoplasms | 8.5% |
| 280 | leiomyosarcoma | 8.5% |
| 281 | liposarcoma | 8.5% |
| 282 | Mesothelioma | 8.5% |
| 283 | Penile Neoplasms | 8.5% |
| 284 | Prostatic Neoplasms | 8.5% |
| 285 | Stomach Neoplasms | 8.5% |
| 286 | synovial sarcoma | 8.5% |
| 287 | Neuroectodermal Tumor, Melanotic | 8.5% |
| 288 | Angiomyolipoma | 8.5% |
| 289 | Clear Cell Sarcoma of Soft Tissue | 8.5% |
| 290 | Alveolar Soft Part Sarcoma | 8.5% |
| 291 | Neuroendocrine Tumors | 8.5% |
| 292 | Sarcoma, Myeloid | 8.5% |
| 293 | Carcinoma, Basal Cell | 8.5% |
| 294 | Brain Stem Neoplasms | 8.5% |
| 295 | Malignant Carcinoid Syndrome | 8.4% |
| 296 | POEMS Syndrome | 8.4% |
| 297 | Lymphangioleiomyomatosis | 8.3% |
| 298 | granulosa cell tumor | 8.3% |
| 299 | Carcinoma, Ovarian Epithelial | 8.3% |
| 300 | Glioblastoma | 8.3% |
| 301 | Neuroblastoma | 8.3% |
| 302 | Glioblastoma Multiforme | 8.3% |
| 303 | Lymphangiectasis, Intestinal | 8.2% |
| 304 | Choroid Plexus Papilloma | 8.2% |
| 305 | Leukemia, Radiation-Induced | 8.1% |
| 306 | Ganglioneuroblastoma | 8.1% |
| 307 | Mesoblastic Nephroma | 8% |
| 308 | Cystadenocarcinoma | 8% |
| 309 | Fibrosarcoma | 8% |
| 310 | Osteosarcoma | 8% |
| 311 | Mucoepidermoid Carcinoma | 8% |
| 312 | Opsoclonus-Myoclonus Syndrome | 7.9% |
| 313 | Adenofibroma | 7.8% |
| 314 | Fibroadenoma | 7.8% |
| 315 | Malignant Fibrous Histiocytoma | 7.8% |
| 316 | Kernicterus | 7.7% |
| 317 | Hypopharyngeal Neoplasms | 7.6% |
| 318 | Pleural Effusion, Malignant | 7.6% |
| 319 | Hypopharyngeal Cancer | 7.6% |
| 320 | Bowen's Disease | 7.6% |
| 321 | Paraganglioma | 7.6% |
| 322 | Rhabdomyosarcoma | 7.6% |
| 323 | Giant Cell Tumor of Bone | 7.6% |
| 324 | Adenomatous Polyposis Coli | 7.6% |
| 325 | Laryngeal neoplasm | 7.5% |
| 326 | Tuberous Sclerosis | 7.5% |
| 327 | Parotid Neoplasms | 7.5% |
| 328 | Prostatic Neoplasms, Castration-Resistant | 7.5% |
| 329 | Nelson Syndrome | 7.4% |
| 330 | Hodgkin Disease | 7.4% |
| 331 | Leukemia, Plasma Cell | 7.4% |
| 332 | Lymphoma, Non-Hodgkin | 7.4% |
| 333 | Renal Cell Carcinoma | 7.4% |
| 334 | Papillary Renal Cell Carcinoma | 7.4% |
| 335 | Dermatofibrosarcoma | 7.3% |
| 336 | Dermatofibrosarcoma Protuberans | 7.3% |
| 337 | Bladder Neoplasm | 7.2% |
| 338 | Kidney Neoplasm | 7.2% |
| 339 | Ureteral Neoplasms | 7.2% |
| 340 | Urethral Neoplasms | 7.2% |
| 341 | Leukoplakia | 7.1% |
| 342 | Lymphoproliferative Disorders | 7.1% |
| 343 | Pancreatic Cyst | 7.1% |
| 344 | Lymphatic Abnormalities | 7.1% |
| 345 | Pheochromocytoma | 7.1% |
| 346 | Alveolar rhabdomyosarcoma | 7.1% |
| 347 | Tonsillar Neoplasms | 7.1% |
| 348 | Carcinoma, Endometrioid | 7% |
| 349 | Barrett Esophagus | 7% |
| 350 | Breast Cyst | 7% |
| 351 | Actinic keratosis | 7% |
| 352 | Mediastinal Cyst | 7% |
| 353 | Neoplasm Invasiveness | 7% |
| 354 | Neoplasm Metastasis | 7% |
| 355 | Neoplasm Recurrence, Local | 7% |
| 356 | Parovarian Cyst | 7% |
| 357 | Pericardial Cyst | 7% |
| 358 | Thymic Cyst | 7% |
| 359 | Carcinogenesis | 7% |
| 360 | Myxoid cyst | 7% |
| 361 | Metastasis | 7% |
| 362 | Cerebellar Neoplasms | 7% |
| 363 | Myelitis, Transverse | 7% |
| 364 | Adenoma | 7% |
| 365 | Ameloblastoma | 7% |
| 366 | Angiokeratoma | 7% |
| 367 | Carcinoma | 7% |
| 368 | Chordoma | 7% |
| 369 | Elephantiasis | 7% |
| 370 | Hemangioma | 7% |
| 371 | hemangiopericytoma | 7% |
| 372 | Hypersplenism | 7% |
| 373 | Lymphangioma | 7% |
| 374 | Mesenchymoma | 7% |
| 375 | Nevus | 7% |
| 376 | Sarcoidosis | 7% |
| 377 | Teratoma | 7% |
| 378 | Hepatoblastoma | 7% |
| 379 | Mixed Tumor, Mullerian | 7% |
| 380 | Germinoma | 7% |
| 381 | Teratocarcinoma | 7% |
| 382 | Angiofibroma | 7% |
| 383 | Elephantiasis Nostras Verrucosa | 7% |
| 384 | Sarcoma | 7% |
| 385 | Epithelioma | 7% |
| 386 | Carcinoid Heart Disease | 6.9% |
| 387 | Sezary Syndrome | 6.8% |
| 388 | Leukemia, T-Cell | 6.7% |
| 389 | Leukemia, B-Cell | 6.7% |
| 390 | Basal Cell Nevus Syndrome | 6.5% |
| 391 | Nasopharyngeal carcinoma | 6.5% |
| 392 | Cecal Neoplasms | 6.4% |
| 393 | Duodenal Neoplasms | 6.4% |
| 394 | Hydatidiform Mole | 6.3% |
| 395 | Lymphoma, Follicular | 6.3% |
| 396 | T-Cell Lymphoma | 6.3% |
| 397 | Mantle cell lymphoma | 6.3% |
| 398 | Neurofibrosarcoma | 6.2% |
| 399 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 6% |
| 400 | Leukemia, Large Granular Lymphocytic | 6% |
| 401 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6% |
| 402 | Appendiceal Neoplasms | 6% |
| 403 | Colonic Neoplasms | 6% |
| 404 | Rectal Neoplasms | 6% |
| 405 | Lymphoma, T-Cell, Cutaneous | 5.8% |
| 406 | Lymphoma, AIDS-Related | 5.8% |
| 407 | Enteropathy-Associated T-Cell Lymphoma | 5.8% |
| 408 | Primary Effusion Lymphoma | 5.8% |
| 409 | Endometrial Stromal Sarcoma | 5.8% |
| 410 | Adenocarcinoma | 5.7% |
| 411 | Carcinoma in Situ | 5.7% |
| 412 | Carcinoma, Transitional Cell | 5.7% |
| 413 | Phyllodes Tumor | 5.7% |
| 414 | Dysgerminoma | 5.7% |
| 415 | Hemangioendothelioma | 5.7% |
| 416 | Lipoma | 5.7% |
| 417 | Lymphohistiocytosis, Hemophagocytic | 5.7% |
| 418 | Myoma | 5.7% |
| 419 | Myxoma | 5.7% |
| 420 | Neuroma | 5.7% |
| 421 | Papilloma | 5.7% |
| 422 | Pseudomyxoma Peritonei | 5.7% |
| 423 | Seminoma | 5.7% |
| 424 | Papillomatosis | 5.7% |
| 425 | Angiolipoma | 5.7% |
| 426 | Myelolipoma | 5.7% |
| 427 | Neoplasms, Bone Tissue | 5.7% |
| 428 | Neoplasms, Fibrous Tissue | 5.7% |
| 429 | Smooth Muscle Tumor | 5.7% |
| 430 | Adenomatosis, Pulmonary | 5.7% |
| 431 | Adenomatous Polyps | 5.7% |
| 432 | Carcinoma, Large Cell | 5.7% |
| 433 | Carcinoma, Small Cell | 5.7% |
| 434 | Desmoplastic Small Round Cell Tumor | 5.7% |
| 435 | Erdheim-Chester Disease | 5.7% |
| 436 | Chondroma | 5.7% |
| 437 | Enchondroma | 5.7% |
| 438 | Nasopharyngeal Neoplasms | 5.7% |
| 439 | Pseudoxanthoma Elasticum | 5.7% |
| 440 | Colorectal Neoplasms | 5.6% |
| 441 | Mucocutaneous Lymph Node Syndrome | 5.6% |
| 442 | Mycosis Fungoides | 5.5% |
| 443 | Lymphomatoid Papulosis | 5.5% |
| 444 | Plasmablastic lymphoma | 5.5% |
| 445 | Denys-Drash Syndrome | 5.5% |
| 446 | Corpus Luteum Cyst | 5.5% |
| 447 | Ovarian Cysts | 5.5% |
| 448 | Granuloma | 5.3% |
| 449 | Splenic Infarction | 5.3% |
| 450 | Histiocytosis, Langerhans-Cell | 5.2% |
| 451 | Pancreatic Pseudocyst | 5.2% |
| 452 | Plasmacytoma | 5.2% |
| 453 | Tumor Lysis Syndrome | 5.2% |
| 454 | Adenoid Cystic Carcinoma | 5.1% |
| 455 | fibroma | 5.1% |
| 456 | Fibromatosis | 5.1% |
| 457 | Osteoblastoma | 5.1% |
| 458 | Osteoma | 5.1% |
| 459 | Rhabdomyoma | 5.1% |
| 460 | Chondromatosis | 5.1% |
| 461 | Adenocarcinoma, Clear Cell | 5.1% |
| 462 | Cholangiocarcinoma | 5.1% |
| 463 | Cervical Intraepithelial Neoplasia | 5.1% |
| 464 | Hemangioblastoma | 5.1% |
| 465 | Lymphoma, Extranodal NK-T-Cell | 5.1% |
| 466 | Lymphatic Metastasis | 5.1% |
| 467 | Neoplasms, Unknown Primary | 5.1% |
| 468 | Leukemic Infiltration | 5.1% |
| 469 | Neoplasm Micrometastasis | 5.1% |
| 470 | Paranasal Sinus Neoplasms | 5% |
| 471 | Anus Neoplasms | 5% |
| 472 | Sigmoid Neoplasms | 5% |
| 473 | Fibromatosis, Aggressive | 4.8% |
| 474 | Fibromatosis, Abdominal | 4.8% |
| 475 | Klatskin Tumor | 4.8% |
| 476 | Maxillary Sinus Neoplasms | 4.7% |
| 477 | Choledochal Cyst | 4.7% |
| 478 | Peutz-Jeghers Syndrome | 4.5% |
| 479 | Sarcoidosis, Pulmonary | 4.3% |
| 480 | Splenic Rupture | 4.2% |
| 481 | Burkitt Lymphoma | 4.1% |
| 482 | Polycystic Ovary Syndrome | 4% |
| 483 | Mastocytoma | 3.8% |
| 484 | Mastocytosis, Systemic | 3.8% |
| 485 | Autoimmune Lymphoproliferative Syndrome | 3.5% |
| 486 | Mastocytosis | 3.4% |
| 487 | Sturge-Weber Syndrome | 3.4% |
| 488 | Cell Transformation, Viral | 3.4% |
| 489 | Splenosis | 3.4% |
| 490 | Gastrointestinal Stromal Tumors | 3.4% |
| 491 | Primary amyloidosis | 3.4% |
| 492 | neurofibroma | 3.3% |
| 493 | Dupuytren Contracture | 2.9% |
| 494 | Urticaria Pigmentosa | 2.9% |
| 495 | Xeroderma Pigmentosum | 2.7% |
| 496 | Zollinger-Ellison syndrome | 2.2% |
| 497 | Radicular Cyst | 2% |
| 498 | Niemann-Pick Disease, Type C | 1.2% |
